Mico BioMed Co. Ltd. (214610) — Cash Flow Reinvestment Rate
Latest as of March 2022:
0.38x
Mico BioMed Co. Ltd. (214610) has a Cash Flow Reinvestment Rate of 0.38x as of March 2022, reinvesting ₩563.24 Million (capex ₩563.24 Million ) from operating cash flow of ₩1.50 Billion. Check 214610 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.38x
(Capex + Investments) / Operating CF
Total Reinvested
₩563.24 Million
Capex + Investments
Operating Cash Flow
₩1.50 Billion
KRW
Capital Expenditures
₩563.24 Million
KRW
Annual Cash Flow Reinvestment Rate for Mico BioMed Co. Ltd. (None–None)
Year-by-year capital reinvestment analysis for Mico BioMed Co. Ltd.. For live market cap and broader valuation context, see 214610 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow